Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Beatriz González-Toledo"'
Autor:
Dara Rodríguez-González, María García-González, Fuensanta Gómez-Bernal, Juan C. Quevedo-Abeledo, Agustín F. González-Rivero, Yolanda Fernández-Cladera, Elena González-López, J. Gonzalo Ocejo-Vinyals, Alejandro Jiménez-Sosa, Beatriz González-Toledo, Miguel Á. González-Gay, Iván Ferraz-Amaro
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 15, p 8360 (2024)
The complement (C) system is implicated in the etiopathogenesis of rheumatoid arthritis (RA). However, there is a lack of studies characterizing all three C pathways in RA patients. This study aimed to evaluate the association between an in-depth exa
Externí odkaz:
https://doaj.org/article/7ad3e76069d04d7eb3705a9e3a333962
Autor:
Rosa Miquel-Rodríguez, Beatriz González-Toledo, María-Vanessa Pérez-Gómez, María Ángeles Cobo-Caso, Patricia Delgado-Mallén, Sara Estupiñán, Coriolano Cruz-Perera, Laura Díaz-Martín, Federico González-Rinne, Alejandra González-Delgado, Armando Torres, Flavio Gaspari, Domingo Hernández-Marrero, Alberto Ortiz, Esteban Porrini, Sergio Luis-Lima
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 9, p 5036 (2024)
Autosomal polycystic kidney disease (ADPKD) is the most common genetic form of kidney failure, reflecting unmet needs in management. Prescription of the only approved treatment (tolvaptan) is limited to persons with rapidly progressing ADPKD. Rapid p
Externí odkaz:
https://doaj.org/article/ff21997bd382469683c57f61322ca280
Autor:
Rosa Miquel, Rodríguez, Sergio, Luis-Lima, Juan Manuel, Fernandez, María Vanesa Pérez, Gómez, Beatriz González, Toledo, Marian, Cobo, Patricia, Delgado-Mallén, Beatriz, Escamilla, Cristina Oramas, Marco, Sara, Estupiñán, Coriolano Cruz, Perera, Natalia Negrín, Mena, Laura Díaz, Martín, Sergio Pitti, Reyes, Ibrahim Hernández, González, Federico, González-Rinne, Alejandra, González-Delgado, Carmen, Ferrer-Moure, Begoña López-Botet, Zulueta, Armando, Torres, Jose Carlos Rodriguez, Pérez, Flavio, Gaspari, Alberto, Ortiz, Esteban, Porrini
Publikováno v:
Journal of Nephrology. 35:2109-2118
Background Autosomal dominant polycystic kidney disease (ADPKD) causes about 10% of cases of end stage renal disease. Disease progression rate is heterogeneous. Tolvaptan is presently the only specific therapeutic option to slow kidney function decli